Quarterly report pursuant to Section 13 or 15(d)

Share-based compensation

v3.23.2
Share-based compensation
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Share-based compensation Share-based compensation
During the three months ended June 30, 2023 and June 30, 2022, the Company recognized $0.3 million and $0.8 million, respectively, of share-based compensation expense. During the six months ended June 30, 2023 and June 30, 2022, the Company recognized $1.7 million and $1.9 million, respectively, of share-based compensation expense.
On November 11, 2019, the Company received shareholder approval for the Amended and Restated 2019 Incentive Award Plan (the “Amended 2019 Plan”). The Amended 2019 Plan provides for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units, other stock or cash-based awards or a dividend equivalent award. The Amended 2019 Plan authorized the issuance of 1,083,334 shares of common stock which was increased to 1,500,000 after the Halo acquisition; the Amended 2019 Plan also provides for an annual increase on the first day of each calendar year beginning on January 1, 2020 and ending on and including January 1, 2029, equal to the lesser of (A) 10% of the shares of common stock outstanding (on an as-converted basis) on the last day of the immediately preceding fiscal year and (B) such smaller number of shares of common stock as determined by the Board; provided, however, not more than 9,000,000 shares of common stock shall be authorized for issuance. The authorized shares for issuance was increased to 2,700,000 on January 1, 2021, increased to 5,614,637 on January 1, 2022 and again increased to 8,557,663 on January 1, 2023.
Stock options
The following table provides detail of the options granted and outstanding (dollars in thousands):
  Options Weighted Average
Exercise Price
Weighted Average Remaining Contractual Life (Years) Aggregate Intrinsic Value
Options outstanding as of December 31, 2022 3,071,187  $ 5.39  7.2 $ — 
Granted —  — 
Forfeited/Expired (178,656) 4.05 
Options outstanding as of March 31, 2023 2,892,531  $ 5.47  6.3 $ — 
Granted — 
Forfeited/Expired (280,689) 4.69 
Options outstanding as of June 30, 2023 2,611,842  $ 5.51  6.2 $ — 
Options exercisable as of June 30, 2023 2,233,624  $ 5.69  5.8 $ — 
Options granted under the Amended 2019 Plan vest over a period of two to three years. All vested options are exercisable and may be exercised through the ten-year anniversary of the grant date (or such earlier date described in the applicable award agreement).
Restricted Stock Awards
In February 2022, the Company granted 218,345 shares of restricted common stock to members of its board of directors under the Amended 2019 Plan as compensation for annual board service. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $0.5 million upon issuance.
During the fourth quarter of 2022, the Company granted 65,555 shares of restricted common stock to a member of its board of directors for service as interim CEO. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $0.1 million upon issuance.
In January 2023, the Company granted 892,860 shares of restricted common stock to members of its board of directors under the Amended 2019 Plan as compensation for annual board service. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $0.5 million upon issuance.
In January 2023, the Company granted 200,000 shares of restricted common stock to certain executives and employees under the Amended 2019 Plan as performance bonus compensation totaling $0.1 million. These restricted stock awards were issued on the grant date with a one year cliff vesting condition and the Company will recognize the expense over the vesting period.
During the first quarter of 2023, the Company granted 18,021 shares of restricted common stock to a member of its board of directors for service as interim CEO. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $0.1 million upon issuance.